An Alternative to Traditional Workflows For Immunogenicity Studies: xMAP® Multiplex Assays Save Time and Resources
Luminex SPONSORED CONTENT

An Alternative to Traditional Workflows For Immunogenicity Studies: xMAP® Multiplex Assays Save Time and Resources

An Alternative to Traditional Workflows For Immunogenicity Studies

In drug discovery and development pipelines, measuring immunogenicity — the body’s ability to produce an immune response — is critical. Immunogenicity studies must be able to detect the presence of anti-drug specific antibodies, determine the titer of those antibodies, and evaluate antibody isotypes effectively. Download this resource to learn how scientists use bead-based multiplexing technology to streamline an immunogenicity testing workflow into a single assay, preserving sample volume and integrity.

Download Now

    Please fill out the information below to download the content. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.